Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 125

Sort by

Sort Order Select

Journal Articles

Psychological Impact in Individuals with Monoclonal Gammopathy of Undetermined Significance and Smoldering Multiple Myeloma

Tanvi H. Patel, Ramya Bachu, Trilok Shrivastava, Jawad Alrawabdeh, Marah Alzubi, Jael Hastings, Harold Dean, Carolina Schinke, Sharmilan Thanendrarajan, Maurizio Zangari, Guido Tricot, Fenghuang Zhan, John D Shaughnessy, Jr, Frits van Rhee, Samer Al Hadidi

Blood (2023) 142 (Supplement 1): 6764.

https://doi.org/10.1182/blood-2023-180964

Published: 2023

Journal Articles

Total Therapy (TT)-4: A Phase 3 Trial Comparing L-TT4 and S-TT4 and Tandem Auto Transplants in Standard Risk Multiple Myeloma

Samer Al Hadidi, Obada Ababneh, Carson W Ercanbrack, Carolina Schinke, Sharmilan Thanendrarajan, Clyde Bailey, Robert Smith, Susan Panozzo, Guido Tricot, Daisy V. Alapat, John D Shaughnessy, Jr, Fenghuang Zhan, Bart Barlogie, Maurizio Zangari, Frits van Rhee

Blood (2023) 142 (Supplement 1): 3594.

https://doi.org/10.1182/blood-2023-181034

Published: 2023

Journal Articles

The BCMA-Targeted Fourth-Generation CAR-T Cells Secreting CST6 Against Multiple Myeloma and Suppresses Osteolytic Lesions

Fumou Sun, Yan Cheng, Jin-Ran Chen, Visanu Wanchai, David E. Mery, Hongwei Xu, Dongzheng Gai, Samer Al Hadidi, Carolina Schinke, Sharmilan Thanendrarajan, Maurizio Zangari, Frits van Rhee, John D Shaughnessy, Jr, Guido Tricot, Fenghuang Zhan

Blood (2023) 142 (Supplement 1): 452.

https://doi.org/10.1182/blood-2023-181853

Published: 2023

Journal Articles

Single Nuclei Multiomics Analysis of Transcriptional and Chromatin Accessibility of Tumor Cells Uncovers Molecular Signatures and Regulatory Elements of Malignant Clonal Evolution in Multiple Myeloma

Visanu Wanchai, Hongwei Xu, Cody Ashby, Frits van Rhee, Guido Tricot, John D Shaughnessy, Jr, Fenghuang Zhan

Blood (2023) 142 (Supplement 1): 87.

https://doi.org/10.1182/blood-2023-181279

Published: 2023

Journal Articles

A 5-Stage System for ASCT Multiple Myeloma

Wancheng Guo, David E. Mery, Eric Siegel, Fumou Sun, Yan Cheng, Visanu Wanchai, Cody Ashby, Clyde Bailey, Daisy V. Alapat, Hongling Peng, Samer Al Hadidi, Sharmilan Thanendrarajan, Carolina Schinke, Maurizio Zangari, Frits van Rhee, Guido Tricot, John D Shaughnessy, Jr, Fenghuang Zhan

Blood (2023) 142 (Supplement 1): 3331.

https://doi.org/10.1182/blood-2023-181117

Published: 2023

Journal Articles

Tumor-Infiltrating Normal B Lymphocytes Have Remarkable Prognostic Effects and Are Crucial for Antitumor Immune Responses in Diffuse Large B-Cell Lymphoma

Blood (2023) 142 (Supplement 1): 429.

https://doi.org/10.1182/blood-2023-179972

Published: 2023

Journal Articles

Sequential Imaging with Diffusion-Weighted Whole-Body MRI (DW-MRI) and PET-CT Identifies Patients at High Risk of Relapse in Multiple Myeloma

Carolina Schinke, Leo Rasche, Cody Ashby, Rudy van Hemert, Sharmilan Thanendrarajan, Samer Al Hadidi, Maurizio Zangari, Clyde Bailey, Daisy V. Alapat, John D Shaughnessy, Jr, Fenghuang Zhan, Bart Barlogie, Frits van Rhee, Niels Weinhold

Blood (2023) 142 (Supplement 1): 882.

https://doi.org/10.1182/blood-2023-180896

Published: 2023

Journal Articles

Suppression of TRIP13 Induces Metabolic Changes and Potentiates Ferroptosis in Multiple Myeloma

Yan Cheng, Fumou Sun, Wancheng Guo, Hongwei Xu, Prasanth Viswanathan, Mark Manzano, Eric Siegel, Samer Al Hadidi, Carolina Schinke, Maurizio Zangari, Marta Chesi, P. Leif Bergsagel, Frits van Rhee, Guido Tricot, John D Shaughnessy, Jr, Fenghuang Zhan

Blood (2023) 142 (Supplement 1): 3309.

https://doi.org/10.1182/blood-2023-187001

Published: 2023

Journal Articles

Development and Validation of an Individualized and Weighted Prognostic Model in Patients with Newly Diagnosed Multiple Myeloma

Wenqiang Yan, Xuehan Mao, David E. Mery, Yan Xu, Weiwei Sui, Shuhui Deng, Dehui Zou, John D Shaughnessy, Jr, Kenneth C. Anderson, Fenghuang Zhan, Lugui Qiu, Gang An

Blood (2023) 142 (Supplement 1): 1967.

https://doi.org/10.1182/blood-2023-182598

Published: 2023

Journal Articles

Global Proteomics Identifies CDK11A/B As Integral to Myeloma Proliferation and High-Risk Disease

David E. Mery, Visanu Wanchai, Cody Ashby, Hongwei Xu, Eric Siegel, Clyde Bailey, Guido Tricot, John D Shaughnessy, Jr, Fenghuang Zhan

Blood (2023) 142 (Supplement 1): 1932.

https://doi.org/10.1182/blood-2023-187592

Published: 2023

Journal Articles

Prognostic Value of Ferritin in ASCT MM Patients: Integration with GEP Models and ISS Series Systems

Wancheng Guo, David E. Mery, Eric Siegel, Fumou Sun, Yan Cheng, Cody Ashby, Daisy V. Alapat, Hongling Peng, Samer Al Hadidi, Sharmilan Thanendrarajan, Carolina Schinke, Maurizio Zangari, Frits van Rhee, Guido Tricot, John D Shaughnessy, Jr, Fenghuang Zhan

Blood (2023) 142 (Supplement 1): 6573.

https://doi.org/10.1182/blood-2023-181254

Published: 2023

Journal Articles

Variability of Definition of High-Risk Multiple Myeloma in Phase III Clinical Trials

Faris Jamal Abu Za'nouneh, Obada Ababneh, Carolina Schinke, Sharmilan Thanendrarajan, Maurizio Zangari, John D Shaughnessy, Jr., Fenghuang Zhan, Frits van Rhee, Samer Al Hadidi

Blood (2022) 140 (Supplement 1): 10116–10117.

https://doi.org/10.1182/blood-2022-158188

Published: 2022

Journal Articles

Clinical Research Focused on Supportive Care in Multiple Myeloma: A Cross Sectional Analysis

Hadeel Al-Zawahreh, Carolina Schinke, Sharmilan Thanendrarajan, Maurizio Zangari, Fenghuang Zhan, John D Shaughnessy, Jr., Frits van Rhee, Samer Al Hadidi

Blood (2022) 140 (Supplement 1): 13240–13241.

https://doi.org/10.1182/blood-2022-159652

Published: 2022

Journal Articles

Immunogenicity of Covid-19 Vaccine Among Multiple Myeloma Patients Post Autologous Stem Cell Transplant

Nishanth Thalambedu, Yetunde Ogunsesan, Jaskirat Sethi, Munawwar Hussain, Lakshmi Yarlagadda, Sravani Gundarlapalli, Horace J. Spencer, Clyde Bailey, Samer Al Hadidi, Sharmilan Thanendrarajan, Maurizio Zangari, John D. Shaughnessy, Jr., Fenghuang Zhan, Juan Carlos Rico Crescencio, Frits van Rhee, Carolina Schinke

Blood (2022) 140 (Supplement 1): 12922–12923.

https://doi.org/10.1182/blood-2022-169353

Published: 2022

Journal Articles

Risk of Infections Associated with the Use of Bispecific Antibodies in Multiple Myeloma: A Pooled Analysis

Farah Mazahreh, Liyan Mazahreh, Carolina Schinke, Sharmilan Thanendrarajan, Maurizio Zangari, John D Shaughnessy, Jr., Fenghuang Zhan, Frits van Rhee, Samer Al Hadidi

Blood (2022) 140 (Supplement 1): 4378.

https://doi.org/10.1182/blood-2022-157858

Published: 2022

Journal Articles

A 12 Gene Signature Accurately Predicts Multiple Myeloma Progression from Monoclonal Gammopathy of Undetermined Significance

Blood (2022) 140 (Supplement 1): 264–265.

https://doi.org/10.1182/blood-2022-163654

Published: 2022

Journal Articles

Under-Representation of Black Patients with Multiple Myeloma in Studies Supporting International Myeloma Working Group Guidelines

Suhib Fahmawi, Carolina Schinke, Maurizio Zangari, Sharmilan Thanendrarajan, John D Shaughnessy, Jr., Fenghuang Zhan, Frits van Rhee, Samer Al Hadidi

Blood (2022) 140 (Supplement 1): 13212–13213.

https://doi.org/10.1182/blood-2022-158346

Published: 2022

Journal Articles

Parameters Influencing Count Recovery Post Autologous Stem Cell Transplantation in Patients with Multiple Myeloma

Yetunde Ogunsesan, Reid D. Landes, Jaskirat Sethi, Munawwar Hussain, Nishanth Thalambedu, Lakshmi Yarlagadda, Sravani Gundarlapalli, Clyde Bailey, Samer Al Hadidi, Sharmilan Thanendrarajan, Maurizio Zangari, John D. Shaughnessy, Jr., Fenghuang Zhan, Frits van Rhee, Carolina Schinke

Blood (2022) 140 (Supplement 1): 10579–10580.

https://doi.org/10.1182/blood-2022-167624

Published: 2022

Journal Articles

The Use and Reporting of Cytogenetics in Phase III Multiple Myeloma Clinical Trials

Obada Ababneh, Faris Jamal Abu Za'nouneh, Carolina Schinke, Sharmilan Thanendrarajan, Maurizio Zangari, John D Shaughnessy, Jr., Fenghuang Zhan, Frits van Rhee, Samer Al Hadidi

Blood (2022) 140 (Supplement 1): 12532–12533.

https://doi.org/10.1182/blood-2022-158282

Published: 2022

Journal Articles

Bispecific CAR-T Cells Targeting Both BCMA and CD24: A Potentially Treatment Approach for Multiple Myeloma

Fumou Sun, Yan Cheng, Bailu Peng, Hongwei Xu, Frits van Rhee, Siegfried Janz, Guido Tricot, John D Shaughnessy, Jr., Fenghuang Zhan

Blood (2021) 138 (Supplement 1): 2802.

https://doi.org/10.1182/blood-2021-148543

Published: 2021

NARROW

Psychological Impact in Individuals with Monoclonal Gammopathy of Undetermined Significance and Smoldering Multiple Myeloma

Total Therapy (TT)-4: A Phase 3 Trial Comparing L-TT4 and S-TT4 and Tandem Auto Transplants in Standard Risk Multiple Myeloma

The BCMA-Targeted Fourth-Generation CAR-T Cells Secreting CST6 Against Multiple Myeloma and Suppresses Osteolytic Lesions

Single Nuclei Multiomics Analysis of Transcriptional and Chromatin Accessibility of Tumor Cells Uncovers Molecular Signatures and Regulatory Elements of Malignant Clonal Evolution in Multiple Myeloma

A 5-Stage System for ASCT Multiple Myeloma

Tumor-Infiltrating Normal B Lymphocytes Have Remarkable Prognostic Effects and Are Crucial for Antitumor Immune Responses in Diffuse Large B-Cell Lymphoma

Sequential Imaging with Diffusion-Weighted Whole-Body MRI (DW-MRI) and PET-CT Identifies Patients at High Risk of Relapse in Multiple Myeloma

Suppression of TRIP13 Induces Metabolic Changes and Potentiates Ferroptosis in Multiple Myeloma

Development and Validation of an Individualized and Weighted Prognostic Model in Patients with Newly Diagnosed Multiple Myeloma

Global Proteomics Identifies CDK11A/B As Integral to Myeloma Proliferation and High-Risk Disease

Prognostic Value of Ferritin in ASCT MM Patients: Integration with GEP Models and ISS Series Systems

Variability of Definition of High-Risk Multiple Myeloma in Phase III Clinical Trials

Clinical Research Focused on Supportive Care in Multiple Myeloma: A Cross Sectional Analysis

Immunogenicity of Covid-19 Vaccine Among Multiple Myeloma Patients Post Autologous Stem Cell Transplant

Risk of Infections Associated with the Use of Bispecific Antibodies in Multiple Myeloma: A Pooled Analysis

A 12 Gene Signature Accurately Predicts Multiple Myeloma Progression from Monoclonal Gammopathy of Undetermined Significance

Under-Representation of Black Patients with Multiple Myeloma in Studies Supporting International Myeloma Working Group Guidelines

Parameters Influencing Count Recovery Post Autologous Stem Cell Transplantation in Patients with Multiple Myeloma

The Use and Reporting of Cytogenetics in Phase III Multiple Myeloma Clinical Trials

Bispecific CAR-T Cells Targeting Both BCMA and CD24: A Potentially Treatment Approach for Multiple Myeloma

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only